Small cap News

Damodaran found that the S&P 500 moved about 0.5% when the 10-year yield changed by more than three basis points.

CEO Peter Beck blamed RKLB’s stock volatility on macro conditions, saying the business has improved across “every single metric.”

The BWET fund primarily tracks tanker rates on the Middle East Gulf-to-China route through the Strait of Hormuz.

Swarmer is planning to expand its defense technology footprint, and the stock has gained 13% year-to-date.

The task force will pursue faster approvals, more spaceports, priority launch corridors and improved airspace integration.

Slotkin called the rumored move a “strategic mistake” that could threaten 1.2 million Michigan auto-related jobs and broader U.S. manufacturing.

Raymond James, UBS, and Canaccord raised their price targets on the stock, while Stifel and Stephens called the post-earnings weakness a buying opportunity.

Datavault AI plans to launch three platforms on Sept. 15 to monetize data and real-world assets.

CEO Phil Sansone said the F-16 win represents another expansion of Mobix Labs’ position across major U.S. military aircraft programs.

Sigma Lithium has disagreed with the court’s decision and said its operations are continuing while it prepares its legal defense.

Oppenheimer raised its SpaceX target to $280, while Gavin Baker said orbital data centers could eventually propel its valuation to $20 trillion.

Wall Street removed the Angelman program from valuation models, slashing price targets by as much as 76% and issuing multiple downgrades.

Rocket Lab’s Electron offers dedicated launch dates, orbits and mission profiles, unlike shared Falcon 9 rideshare missions.

ASTS offers “damn compelling” direct-to-cell potential, but Feroldi warned that “50 things” could go wrong before commercialization.

Investors are considering higher losses, unchanged guidance, and possible growth from major business partnerships.

GoPro’s Starman Optical merger offers shareholders cash and a stake in the combined business.

BofA retained a ‘Buy’ rating on RKLB with 72% implied upside, but maintained ‘Underperform’ ratings on RDW and LUNR.

Retail traders viewed the Merida acquisition as evidence that Big Pharma will pay rich premiums for immune-focused platforms.

YouTuber Markiplier has bought 8.5% of GoPro, boosting retail interest.

David Bailey said Bitcoin’s corporate adoption is a part of its wider growth, as Nakamoto shifts toward M&A and cash-generating businesses.

A presidential commission has 120 days to recommend the academy’s curriculum, governance, location, admissions and service requirements.

Build-A-Bear stock plunged after a weaker outlook, prompting Michael Burry to reassess his investment thesis.

The AI rally put Burry’s bearish stance under pressure as Palantir, CoreWeave, Oracle, Micron, Tesla, Nebius and Nvidia all climbed during August.

An AstraZeneca sales executive called the Phase 3 Regal trial a “game changer” for AML patients in their first or second complete remission.

Palihapitiya praised CEO Marc Benioff as “too good” and said he expects Salesforce to make good deals as the AI ecosystem evolves.

Burry’s Nvidia calls gained 50% to 60% in under a day after the stock rallied about 9%.

Hyperliquid Strategies reported $305.5 million in fiscal-year net income, driven largely by unrealized gains on its HYPE holdings.

High short interest in Wendy’s is fueling retail speculation about a potential short squeeze.

ARK sees a path toward custom cancer treatments for every patient, though current costs of $200,000-$300,000 remain a major hurdle.

Farrar said AST may need telecom backing for a major spectrum deal and faces heavy competition from SpaceX.

Virginia Retirement System disclosed SLS and IBRX stakes worth nearly $909,000 combined.

Polestar is pivoting toward Europe, which generated nearly 80% of its first-half retail sales.

Rocket Lab’s Neutron could capture medium-lift demand as Falcon 9 commercial capacity tightens.

Hims faces an estimated $75,000 surcharge and must lower its dispute rate below 1.5%.

BTC Digital announced that its Georgia cryptocurrency mining project was nearing deployment.

Moderna soared 177% Wednesday, while Merck gained 13% and the rally spread to BioNTech, Arcturus, Tempus AI and Novavax.

SpaceX could gain from fewer Starship bottlenecks and NASA’s Moon-Mars push.

ASTS already has FCC approval to test the same frequencies with up to 100 commercially available phones near Midland and Lanham through Sept.12.

China urged the U.S. to remove new tariffs on drones and related parts.

The breakthrough sparked a broad biotech rally, lifting Merck, BioNTech, Arcturus, cancer-treatment developers, gene-editing stocks and biotech ETFs.

Wood said soaring memory prices will encourage engineers to develop cheaper alternatives and attract additional supply.

Investors weigh Datavault AI’s tokenization backlog, AI infrastructure expansion, and revenue potential.

Morgan Stanley, UBS, Bank of America, Susquehanna and Millennium collectively added about 36 million Nio shares.

According to TheFly, Compass Point has a ‘Buy’ rating on Gorilla Technology shares with a $44 price target.

Analysts at Cantor Fitzgerald raised their price target on Duos to $27 from $26 while maintaining an ‘Overweight’ rating, implying an upside potential of about 118% from current levels.

A separate pediatric study delivered “striking” WT1 vaccine results, supporting GPS’s scientific rationale, the company's CEO said.

The sell-offs followed a failed trial, a massive recall, and a CEO's exit.

Duos Technologies said that the agreements cover an aggregate 55 MW of AI facility capacity across multiple U.S. data center sites

This comes as Serve Robotics looks to put more robots to work following its recent split with Uber Eats, with the company also launching a new micro-depot model and expanding beyond sidewalk delivery.

Critical Metals advances Tanbreez drilling, construction and pilot-plant work.